Cargando…
Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking
Gyejibokryeong-hwan (GBH) is a traditional formula comprised of five herbal medicines that is frequently used to treat blood stasis and related complex multifactorial disorders such as atherosclerosis. The present study used network pharmacology and molecular docking simulations to clarify the effec...
Autores principales: | Lee, A Yeong, Lee, Joo-Youn, Chun, Jin Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764045/ https://www.ncbi.nlm.nih.gov/pubmed/33321972 http://dx.doi.org/10.3390/plants9121750 |
Ejemplares similares
-
The genotoxicity of an aqueous extract of Gyejibokryeong-hwan
por: Lee, Mee-Young, et al.
Publicado: (2018) -
Elucidating the potential pharmaceutical mechanism of Gyejibokryeong-hwan on rosacea using network analysis
por: Kim, Jundong, et al.
Publicado: (2023) -
Antineuroinflammatory and Neuroprotective Effects of Gyejibokryeong-Hwan in Lipopolysaccharide-Stimulated BV2 Microglia
por: Park, Bo-Kyung, et al.
Publicado: (2019) -
Antidepressant-Like Effects of Gyejibokryeong-hwan in a Mouse Model of Reserpine-Induced Depression
por: Park, Bo-Kyung, et al.
Publicado: (2018) -
Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial
por: Choi, Yujin, et al.
Publicado: (2022)